Chang Jeffrey S, Wrensch Margaret R, Hansen Helen M, Sison Jennette D, Aldrich Melinda C, Quesenberry Charles P, Seldin Michael F, Kelsey Karl T, Kittles Rick A, Silva Gabriel, Wiencke John K
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Int J Cancer. 2008 Nov 1;123(9):2095-104. doi: 10.1002/ijc.23801.
Few studies on the association between nucleotide excision repair (NER) variants and lung cancer risk have included Latinos and African Americans. We examine variants in 6 NER genes (ERCC2, ERCC4, ERCC5, LIG1, RAD23B and XPC) in association with primary lung cancer risk among 113 Latino and 255 African American subjects newly diagnosed with primary lung cancer from 1998 to 2003 in the San Francisco Bay Area and 579 healthy controls (299 Latinos and 280 African Americans). Individual single nucleotide polymorphism and haplotype analyses, multifactor dimensionality reduction (MDR) and principal components analysis (PCA) were performed to assess the association between 6 genes in the NER pathway and lung cancer risk. Among Latinos, ERCC2 haplotype CGA (rs238406, rs11878644, rs6966) was associated with reduced lung cancer risk [odds ratio (OR) of 0.65 and 95% confidence interval (CI): 0.44-0.97], especially among nonsmokers (OR = 0.29; 95% CI: 0.12-0.67). From MDR analysis, in Latinos, smoking and 3 SNPs (ERCC2 rs171140, ERCC5 rs17655 and LIG1 rs20581) together had a prediction accuracy of 67.4% (p = 0.001) for lung cancer. Among African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88). Our study suggests different elements of the NER pathway may be important in the different ethnic groups resulting either from different linkage relationship, genetic backgrounds and/or exposure histories.
关于核苷酸切除修复(NER)基因变异与肺癌风险之间关联的研究,很少将拉丁裔和非裔美国人纳入其中。我们检测了6个NER基因(ERCC2、ERCC4、ERCC5、LIG1、RAD23B和XPC)的变异,这些变异与1998年至2003年在旧金山湾区新诊断为原发性肺癌的113名拉丁裔和255名非裔美国患者以及579名健康对照者(299名拉丁裔和280名非裔美国人)的原发性肺癌风险相关。进行了个体单核苷酸多态性和单倍型分析、多因素降维分析(MDR)和主成分分析(PCA),以评估NER途径中6个基因与肺癌风险之间的关联。在拉丁裔中,ERCC2单倍型CGA(rs238406、rs11878644、rs6966)与肺癌风险降低相关[比值比(OR)为0.65,95%置信区间(CI):0.44 - 0.97],尤其是在不吸烟者中(OR = 0.29;95% CI:0.12 - 0.67)。从MDR分析来看,在拉丁裔中,吸烟以及3个单核苷酸多态性(ERCC2 rs171140、ERCC5 rs17655和LIG1 rs20581)共同对肺癌的预测准确率为67.4%(p = 0.001)。在非裔美国人中,ERCC5 His1104Asp(rs17655)的His/His基因型与肺癌风险增加相关(OR = 1.78;95% CI:1.09 - 2.91),而LIG1单倍型GGGAA(rs20581、rs156641、rs3730931、rs20579和rs439132)与肺癌风险降低相关(OR = 0.61;95% CI:0.42 - 0.88)。我们的研究表明,NER途径的不同因素在不同种族群体中可能很重要,这可能是由于不同的连锁关系、遗传背景和/或暴露史所致。